abstract |
The present invention generally relates to compounds that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing such compounds, and methods of treating proliferative and regulated apoptotic disorders, such as cancer, using the compounds of the invention . |